Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.

MLA

Patel, Jai N., et al. “Pharmacogenetic and Clinical Predictors of Voriconazole Concentration in Hematopoietic Stem Cell Transplant Recipients Receiving CYP2C19-Guided Dosing.” The Pharmacogenomics Journal, vol. 23, no. 6, Nov. 2023, pp. 201–09. EBSCOhost, https://doi.org/10.1038/s41397-023-00320-z.

APA

Patel, J. N., Robinson, M., Morris, S. A., Jandrisevits, E., Lopes, K. E., Hamilton, A., Steuerwald, N., Druhan, L. J., Avalos, B., Copelan, E., Ghosh, N., & Grunwald, M. R. (2023). Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. The Pharmacogenomics Journal, 23(6), 201–209. https://doi.org/10.1038/s41397-023-00320-z

Chicago

Patel, Jai N, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Alicia Hamilton, Nury Steuerwald, et al. 2023. “Pharmacogenetic and Clinical Predictors of Voriconazole Concentration in Hematopoietic Stem Cell Transplant Recipients Receiving CYP2C19-Guided Dosing.” The Pharmacogenomics Journal 23 (6): 201–9. doi:10.1038/s41397-023-00320-z.